Triclabendazole-13C, d3
Triclabendazole-13C, d3 is the 13C- and deuterium labeled Triclabendazole[1].
Product Specifications
CAS Number
2938916-53-9
Product Name Alternative
CGA89317-13C, d3
UNSPSC
12352005
Target
Isotope-Labeled Compounds; Microtubule/Tubulin; Parasite
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection; Cell Cycle/DNA Damage; Cytoskeleton; Others
Applications
COVID-19-anti-virus
Field of Research
Infection
Solubility
10 mM in DMSO
Smiles
ClC1=C(Cl)C(OC2=C(Cl)C=C3C(N=C(S[13C]([2H])([2H])[2H])N3)=C2)=CC=C1
Molecular Formula
C13 13CH6D3Cl3N2OS
Molecular Weight
363.67
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-223.|[2]Fairweather, I., Triclabendazole: new skills to unravel an old (ish) enigma. J Helminthol, 2005. 79 (3) : p. 227-34.|[3]Moll, L., et al., Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands. Vet Parasitol, 2000. 91 (1-2) : p. 153-8.|[4]Robinson, M.W., et al., Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole. Parasitology, 2002. 124 (Pt 3) : p. 325-38.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A2299-11E-ML405 100 µL
APOL1 (BH3 Domain) (Apolipoprotein L1, Apolipoprotein L-I, ApoL-I, Apolipoprotein L, Apo-L, ApoL) (MaxLight 405) discontinued
Sign In for Pricing
View Details